Atlas Trials

A Safety and Efficacy Study of Infusions of HepaStem in Urea Cycle Disorders Pediatric Patients

Clinical trial NCT03884959 · WITHDRAWN

Trial details

NCT number
NCT03884959
Sponsor
HLB Cell Co., Ltd.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Urea Cycle Disorder
Start date
2018-07-12
Primary completion
2020-11-04
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.